Article info

Download PDFPDF
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort

Authors

  1. Correspondence to Professor Adrian Ciurea, Rheumatology, University Hospital Zurich, 8091 Zurich, Switzerland; adrian.ciurea{at}usz.ch
View Full Text

Citation

Micheroli R, Tellenbach C, Scherer A, et al
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort

Publication history

  • Received June 24, 2019
  • Revised May 14, 2020
  • Accepted June 2, 2020
  • First published June 24, 2020.
Online issue publication 
August 14, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.